Semi-Annual Statement Of Income And Retained Earnings

Sumitomo Pharma Co., Ltd. - Filing #7249083

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
11,603,000,000 JPY
-50,004,000,000 JPY
Non-operating income
Non-operating income
10,446,000,000 JPY
48,224,000,000 JPY
Non-operating expenses
Non-operating expenses
10,021,000,000 JPY
4,747,000,000 JPY
Ordinary profit (loss)
12,028,000,000 JPY
-6,527,000,000 JPY
Extraordinary income
Extraordinary income
115,090,000,000 JPY
22,800,000,000 JPY
Extraordinary losses
Extraordinary losses
13,127,000,000 JPY
594,841,000,000 JPY
Profit (loss) before income taxes
113,991,000,000 JPY
-578,568,000,000 JPY
Income taxes - current
203,000,000 JPY
386,000,000 JPY
Income taxes - deferred
7,601,000,000 JPY
9,166,000,000 JPY
Profit (loss)
106,187,000,000 JPY
106,187,000,000 JPY
106,187,000,000 JPY
106,187,000,000 JPY
-588,120,000,000 JPY
-588,120,000,000 JPY
-588,120,000,000 JPY
-588,120,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.